Zubsolv
NDC 54123-907, buprenorphine hydrochloride and naloxone hydrochloride, tablet, orally disintegrating, from Orexo US, Inc..
- Product NDC
- 54123-907
- Status
- Listed
- Labeler
- Orexo US, Inc.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204242
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/54123-907 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE.7 mg/1
- NALOXONE HYDROCHLORIDE.18 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54123-907-30 | 54123090730 | 3 BLISTER PACK in 1 CARTON (54123-907-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5f5cfcfe-d52b-49e6-8fe4-550477332dd2NADAC price for package 54123090730
GET /v1/drugs/nadac/54123090730
Use it
Look up 54123-907 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54123-907 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54123-907. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.